Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
14.16
+0.87 (6.55%)
At close: Sep 26, 2025, 4:00 PM EDT
13.89
-0.27 (-1.91%)
After-hours: Sep 26, 2025, 6:58 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $1.98 billion as of September 26, 2025. Its market cap has increased by 68.84% in one year.
Market Cap
1.98B
Enterprise Value
1.80B
1-Year Change
68.84%
Ranking
Category
Stock Price
$14.16
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $1.98B, an increase of 1,492.66%. That is a compound annual growth rate of 70.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 1.98B | 129.71% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |